MetaSight Diagnostics
Rehovot
About MetaSight Diagnostics
MetaSight Diagnostics, a health technology company, is on a mission to develop affordable and precise liquid biopsy diagnostics for the early detection of a wide range of chronic and acute diseases by leveraging proprietary mass spectrometry technologies (metabolomics, lipidomics, and proteomics).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $8.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2024)
- Website: metasightdx.com
- Phone: +972-3-56473635
Industries & Categories
Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/metasight-diagnostics-18960 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.